使用人工智能增强的综合生物物理研究,准确地描述HSP90护手抑制剂的结合动力学和Allosteric机制
Chao Xu1, Xianglei Zhang1, Lianghao Zhao1
1Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai 201210, China.
JACS Au
|April 26, 2024
概括
定量结构-动力学关系模型预测了热冲击蛋白90α抑制剂的药物标结合动力学. 这些模型通过评估药物位的停留时间和了解分子机制,有助于发现新药.
科学领域:
- 药理学和计算化学
- 药物的发现和开发.
- 结构生物学是结构生物学.
背景情况:
- 药物结合动力学对于体内疗效至关重要,但预测它们是复杂的.
- 预测结合动学的现有方法在效率和准确性上是有限的.
- 热冲击蛋白90α (HSP90α) 是药物开发中的一个关键目标.
研究的目的:
- 开发定量结构动力学关系 (QSKR) 模型,用于预测HSP90α抑制剂的解离速率常数 (koff).
- 评估结构因素,如疏水性和键相互作用对结合动力学的影响.
- 在发现新型N终端HSP90α (N-HSP90α) 抑制剂时应用QSKR模型.
主要方法:
- 开发使用132个抑制剂的QSKR模型,以向HSP90α的ATP结合域.
- 预测解离速率常数 (koff) 以评估药物点的停留时间.
- 应用QSKR模型用于新抑制剂的发现和实验验证.
- 进行X射线晶体学以确定apo N-HSP90α形状.
- 模拟分子动力学以分析形状变化.
主要成果:
- QSKR模型显示了koff.的良好预测性能.
- 鉴定出疏水性和键相互作用是影响koff.koff.的重要因素.
- 模型成功地协助发现了新的N-HSP90α抑制剂.
- 在apo N-HSP90α中通过X射线晶体学观察循环中间形状的第一次观察.
- 分子动力学模拟阐明了影响结合动力学的结构动力学.
结论:
- QSKR建模是预测药物标结合动力学的可行方法.
- 了解HSP90α的结构动态对于优化药物设计至关重要.
- 这项研究为开发涉及HSP90α抑制剂的向治疗策略提供了宝贵的见解.
相关概念视频
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Protein-Drug Binding: Determination Methods
168
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
168
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K


